Posted on July 23rd, 2010
A woman in Georgia has filed a lawsuit claiming to have been harmed by her prescription of a generic version of the drug Reglan.
According to court documents, Susan Swicegood claims a generic brand of Reglan caused her to contract a rare neurological disorder – tardive dyskinesia. Pharmaceutical company Pliva is accused of not including warnings about tardive dyskinesia in the medical reference book, Physician’s Desk Reference. Swicegood claims the lack of this crucial information about possible side effects prevented her and her doctor from making an informed decision about her treatment.
Reglan, also labeld as generic metoclopramide, provides relief from gastrointestinal problems like delayed gastric emptying, diabetic gastroparesis, and gastroesophageal reflux (GERD). The FDA ordered makers of the drug to add a black box warning about tardive dyskinesia in the last year.
For sound legal advice and assistance regarding Reglan side-effects and injury liability, please contact the Reglan Tardive Dyskinesia lawyers of Williams Kherkher today at 800-781-3955.
Posted on July 9th, 2010
Another lawsuit against the maker of the drug Reglan was filed in June, according to court documents.
The newest lawsuit was filed by Israel Bennet, who claims he was prescribed the drug reglan to treat Gastroesophageal Reflux Disease. Bennett says he took the drug regularly for almost five months until he was diagnosed with Tardive Dyskensia. The lawsuit contends that the drug’s manufacturer did not provide him with the right details of the Reglan drug on a long-term basis, and actually provided incorrect and disingenuous information.
Tardive Dyskinesia is a movement disorder characterized by painful and uncontrolled movement of the facial muscles and extremities. Symptoms often include unintentional lip smacking, grimacing, and lip puckering.
If you or a loved one has become ill after use Reglan, contact the Reglan Tardive Dyskinesia attorney of Williams Kherkher by calling 800-761-3187.
Posted on June 25th, 2010
Tardive dyskinesia is a movement disorder that has been linked to long-term exposure to the drug Reglan.
Tardive dyskinesia is characterized by involuntary, repetitive, and purposeless movements. Common manifestations of the disorder occur in the facial muscles. Involuntary grimacing, tongue protrusion, lip smacking, puckering, pursing of the lips, and rapid eye blinking are common in people with the disorder. Rapid movements of the arms or legs can also occur.
Tardive dyskinesia can become socially disabling. People affected by the disorder often isolate themselves due to a perceived societal stigma.
Hundreds of lawsuits have been filed in the United States against the makers of the reflux medication Reglan. The drug is prescribed as short-term therapy for nausea symptomatic gastroesophageal reflux and acute and recurrent diabetic gastroparesis, however long-term exposure to the drug can result in tardive dyskensia.
For sound legal advice and assistance regarding Reglan side-effects and injury liability, please contact the Reglan lawyers of Williams Kherkher today at 800-781-3955.
Posted on June 25th, 2010
A man from Jefferson Parish, Louisiana is suing the manufacturer of a reflux medicine claiming the drug is to blame for his nervous system disorder.
Isreal Bennett filed a lawsuit in the Federal Court of New Orleans against Qualitest Pharmaceuticals earlier this month. Bennett says he was prescribed the drug Reglan to treat reflux from December 2008 through May 2009. The lawsuit claims he was later diagnosed with tardive dyskensia, a disorder that affects the nervous system and causes uncontrollable muscle movements. Bennett claims that the drug caused serious and permanent injury to his central nervous system and extrapyramidal motor system.
The lawsuit contends that Qualitest Pharmaceuticals provided inaccurate, misleading, incomplete, false and otherwise inadequate information concerning the side effects of long-term exposure to Reglan. Bennett is seeking damages for medical expenses, physical pain and suffering, mental anguish, physical disfigurement, physical impairment, loss of earnings, loss of earning capacity, court costs and interest.
If you have developed tardive dyskinesia after using the drug Reglan, you may be eligible for compensation from pharmaceutical companies. Contact the Reglan lawsuit attorneys of Williams Kherkher at 800-761-3187 today to discuss your rights and options.
Posted on June 18th, 2010
Neurocrine Biosciences, a California-based pharmaceutical firm, has announced an intention to press their tardive dyskinesia treatment into US trials under the federal Food & Drug Administration’s Investigational New Drug program.
A previous trial taken up in Canada among healthy male volunteer candidates offered positive feedback, showing no major negative reactions to the drug treatment, including no substantially abnormal ECG findings. The company characterized the drug’s performance in these first phase tests as well-tolerated and working toward its primary function.
The treatment process inhibits brain chemicals that off-set the levels of dopamine that the brain receives in communications between nerves. Neurocrine notes that this drug also marginalizes any change to other monoamines in the brain, which otherwise could have increased side-effects.
This drug has been offered to the public as a possible treatment for not only tardive dyskinesia, but similar disorders like Tourette’s syndrome and even some forms of schizophrenia.
If you have developed tardive dyskinesia after using the drug Reglan, you may be eligible for compensation from pharmaceutical companies. Contact the Reglan lawsuit attorneys of Williams Kherkher at 800-761-3187 today to discuss your rights and options.
Posted on June 16th, 2010
Since the past year, a black box warning label has marked Reglan as one of the most dangerous prescription drugs on the market. However, the label does not address studies that prove that Reglan does not even live up to its expectations as an effective drug.
The Food & Drug Administration originally approved Reglan in 1979 to combat gastrointestinal problems, especially gastroparesis and gastroesophageal reflex disease. While it took 30 years to issue the black box label to warn patients about possible complications, it did not take 30 years to publish a study to prove that the drug had minimal effectiveness to match its dangerousness.
Studies published in 1975, 1983, and 2006 all pointed to weak or non-existent responses to the drug treatment. In comparison, 1983, 1984, and 1992 saw studies pointing out the risks of Reglan.
Reglan is only supposed to be taken for short-term treatment of gastrointestinal ailments, but has been proven to be ineffective for many of the most needy patients suffering from these disorders.
If you or someone you love has been diagnosed with tardive dyskinesia due to Reglan use, you may be entitled to compensation for your medical bills and suffering. Contact the Reglan tardive dyskenesia lawsuit attorneys of Williams Kherkher today by calling 800-761-3187.
Posted on June 4th, 2010
With reports of Reglan-related tardive dyskinesia coming to the forefront of numerous lawsuits, it appears that the disorder can affect any number of users along possible demographic lines.
The medication was used beyond its guidelines, originally establishing a three-month period in which the drug could be used before complications could set in. As a result, Reglan accounts for the primary cause of tardive dyskinesia in the United States of America today. Following studies and lawsuits, the Food & Drug Administration put a warning on the drug, noting its connection to tardive dyskinesia.
Although studies have proven that elderly and female patients are more likely to develop the disorder after using the drug, new concerns have brought to light the presence of the drug-related disorder in infants, as well as less talked about cases in otherwise healthy adults. When an adult in their prime develops tardive dyskinesia, the disorder can move from small uncontrollable movements to worsened jerks and spasms. In some industries, the problems associated with this disorder can cause employees to lose their jobs, compromising their livelihoods.
If you or someone you love has been diagnosed with tardive dyskinesia after a treatment that included Reglan, you may be eligible for compensation. Contact the Reglan lawsuit attorneys of Williams Kherkher by calling 800-761-3187 today.
Posted on May 21st, 2010
Heartburn is a common problem among many people. It occurs when the LES, located between the stomach and the esophagus, becomes weakened and allows stomach acid to splash back into the throat.
Decrease your risk of heartburn by taking some precautionary steps:
- Avoid foods that trigger your heartburn. Many people experience heartburn after eating citrus, tomatoes, spicy foods, caffeine, mints, and chocolate.
- Allow at least two hours between eating and laying down
- If you are overweight, change your eating habits and introduce exercise into your daily routine
- Avoid nicotine and alcohol
By taking preventative steps, you may be able to keep your heartburn under control.
Unfortunately, some people who experience heartburn have been prescribed Reglan, a drug designed to treat chronic heartburn, that can cause much more serious medical conditions. To learn more about your rights and legal options after taking Reglan, contact the Reglan lawsuit attorneys of Williams Kherkher today at 800-761-3187.
Posted on May 13th, 2010
Following an April case, fears are amounting over use of generic forms of Reglan. Although Federal law requires generic brands to follow a similar warning label and to report cases of negative reactions, many are concerned that these standards are less enforceable in a wider market.
These fears compound with new healthcare reforms, which will make prescription pharmaceuticals more affordable, and therefore available, for patients. In the April case, the plaintiff’s suit against Wyeth and Schwartz, the corporations responsible for Reglan’s production, failed to provide prior authority that could hold a original manufacturer responsible for similar generic drugs.
With less enforcement from the FDA over generic brands, and a possible explosion in the market, some fear that Reglan poses to endanger a new, greater population in the near future.
If you or someone you love has suffered from averse side-effects due to the prescription drug Reglan, call the Reglan tardive dyskinesia attorneys of Williams Kherkher at 800-781-3955 today.
Posted on May 7th, 2010
Researchers are growing concerned about the rise of Reglan side effects in newborns due to the increased prescription of the drug to premature infants.
Reglan, a drug that treats acid reflux, was never approved for infants and was only recommended for short term use by the United States Food and Drug Administration. Last year, the FDA issued a black-box warning to inform physicians and the public of the link between Reglan and serious movement disorders like tardive diskinesia.
The rising use of the drug among newborns has many researchers worried that new side effects and previously unknown health concerns will appear. “Because Reglan has been on the market for over thirty years, many physicians assume the drug is safe and prescribe it for various off-label uses,” said Scott Nabers, a health advocate.
If you or someone you love has suffered serious side effects due to the prescription drug Reglan, contact the Reglan lawsuit attorneys of Williams Kherkher at 800-761-3187 today.
